# Paul Aisen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-aisen-2/

## Facts

| Field | Value |
| --- | --- |
| Citations | 66,130 |
| Field | Alzheimer's disease research and treatments |
| h-index | 100 |
| i10-index | 256 |
| Last Known Institution | University of Southern California |
| OpenAlex ID | https://openalex.org/A5108408168 |
| Works | 414 |

## Researcher papers

- [Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease](https://scholariq.org/papers/toward-defining-the-preclinical-stages-of-alzheimer-s-disease-recommendations/)
- [Lecanemab in Early Alzheimer’s Disease](https://scholariq.org/papers/lecanemab-in-early-alzheimer-s-disease/)
- [Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease](https://scholariq.org/papers/clinical-and-biomarker-changes-in-dominantly-inherited-alzheimer-s-disease/)
- [Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria](https://scholariq.org/papers/preclinical-alzheimer-s-disease-definition-natural-history-and-diagnostic/)
- [Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease](https://scholariq.org/papers/phase-3-trials-of-solanezumab-for-mild-to-moderate-alzheimer-s-disease/)
- [Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis](https://scholariq.org/papers/early-role-of-vascular-dysregulation-on-late-onset-alzheimer-s-disease-based-on/)
- [Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference](https://scholariq.org/papers/uncovering-the-heterogeneity-and-temporal-complexity-of-neurodegenerative/)
- [On the path to 2025: understanding the Alzheimer’s disease continuum](https://scholariq.org/papers/on-the-path-to-2025-understanding-the-alzheimer-s-disease-continuum/)
- [Drug development in Alzheimer’s disease: the path to 2025](https://scholariq.org/papers/drug-development-in-alzheimer-s-disease-the-path-to-2025/)
- [Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease](https://scholariq.org/papers/functional-brain-architecture-is-associated-with-the-rate-of-tau-accumulation-in/)
- [Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE](https://scholariq.org/papers/ferritin-levels-in-the-cerebrospinal-fluid-predict-alzheimer-s-disease-outcomes/)

## Researcher topics

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)
- [Functional Brain Connectivity Studies](https://scholariq.org/topics/functional-brain-connectivity-studies/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)

## Researcher university

- [University of Southern California](https://scholariq.org/institutions/university-of-southern-california/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.